Company profile
Epion Therapeutics company profile
Epion is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally. Their EpiSmart approach is a transformative cross-linking system designed to treat keratoconus without disrupting the epithelium, allowing for a rapid return to normal activities. Epion was founded and is supported by experts in the field, including Michael W. Belin, MD, Chief Medical Officer, who developed the Belin ABCD Progression Display, which is able to identify keratoconus progression earlier than previously relied upon metrics.
Business identity
- Website
- https://www.epiontx.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2012-01-01, Year
Headquarters
- Headquarters
- Prairie City, Iowa, United States
- Postal code
- 01803
- Country code
- US
- Continent
- North America